• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Polymerase Chain Reaction-Based Malaria Diagnosis Can Be Increasingly Adopted during Current Phase of Malaria Elimination in India.基于聚合酶链反应的疟疾诊断在印度当前疟疾消除阶段可得到越来越多的采用。
Am J Trop Med Hyg. 2022 Feb 7;106(4):1005-1012. doi: 10.4269/ajtmh.21-0966. Print 2022 Apr 6.
2
Prevalence of submicroscopic malaria in low transmission state of Punjab: A potential threat to malaria elimination.旁遮普邦低传播状态下亚显微疟原虫的流行情况:对疟疾消除的潜在威胁
J Vector Borne Dis. 2019 Jan-Mar;56(1):78-84. doi: 10.4103/0972-9062.257780.
3
Malaria control initiatives that have the potential to be gamechangers in India's quest for malaria elimination.在印度消除疟疾的征程中,有可能成为变革者的疟疾控制举措。
Lancet Reg Health Southeast Asia. 2022 May 28;2:100009. doi: 10.1016/j.lansea.2022.04.005. eCollection 2022 Jul.
4
Additional burden of asymptomatic and sub-patent malaria infections during low transmission season in forested tribal villages in Chhattisgarh, India.印度恰蒂斯加尔邦森林部落村庄低传播季节无症状和亚临床疟原虫感染的额外负担。
Malar J. 2017 Aug 8;16(1):320. doi: 10.1186/s12936-017-1968-8.
5
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
6
A large proportion of asymptomatic Plasmodium infections with low and sub-microscopic parasite densities in the low transmission setting of Temotu Province, Solomon Islands: challenges for malaria diagnostics in an elimination setting.在所罗门群岛的低传播环境下,在坦莫图省存在大量无症状且寄生虫密度低和亚显微的疟原虫感染:消除环境下疟疾诊断的挑战。
Malar J. 2010 Sep 7;9:254. doi: 10.1186/1475-2875-9-254.
7
Field evaluation of a real-time fluorescence loop-mediated isothermal amplification assay, RealAmp, for the diagnosis of malaria in Thailand and India.实时荧光环介导等温扩增检测法(RealAmp)在泰国和印度用于疟疾诊断的现场评估。
J Infect Dis. 2014 Oct 15;210(8):1180-7. doi: 10.1093/infdis/jiu252. Epub 2014 May 1.
8
Performance evaluation of RDT, light microscopy, and PET-PCR for detecting Plasmodium falciparum malaria infections in the 2018 Zambia National Malaria Indicator Survey.RDT、光学显微镜和 PET-PCR 检测 2018 年赞比亚国家疟疾指标调查中恶性疟原虫疟疾感染的性能评估。
Malar J. 2021 Sep 28;20(1):386. doi: 10.1186/s12936-021-03917-6.
9
What is the burden of submicroscopic malaria in pregnancy in central India?印度中部地区孕期亚显微疟原虫感染的负担如何?
Pathog Glob Health. 2015 Feb;109(1):30-8. doi: 10.1179/2047773215Y.0000000002. Epub 2015 Jan 28.
10
Assessment of ultra-sensitive malaria diagnosis versus standard molecular diagnostics for malaria elimination: an in-depth molecular community cross-sectional study.超敏疟疾诊断与标准分子诊断在疟疾消除中的评估:深入的分子社区横断面研究。
Lancet Infect Dis. 2018 Oct;18(10):1108-1116. doi: 10.1016/S1473-3099(18)30411-0. Epub 2018 Aug 28.

引用本文的文献

1
Transfusion-transmitted spp. infections and safety challenges for malaria in the Indian subcontinent: a systematic review.印度次大陆输血传播的疟原虫感染及疟疾安全挑战:一项系统评价
Lancet Reg Health Southeast Asia. 2025 Jul 22;40:100641. doi: 10.1016/j.lansea.2025.100641. eCollection 2025 Sep.
2
Molecular detection of sub-microscopic infections and Plasmodium falciparum histidine-rich protein-2 and 3 gene deletions in pre-elimination settings of South Africa.南非消除前环境中亚微观感染的分子检测和恶性疟原虫组氨酸丰富蛋白-2 和 3 基因缺失。
Sci Rep. 2024 Jul 11;14(1):16024. doi: 10.1038/s41598-024-60007-8.
3
Prevalence and Correlates of Malnutrition in Nuh District, Haryana State, India.印度哈里亚纳邦努哈地区营养不良的流行情况及其相关因素。
Am J Trop Med Hyg. 2024 Feb 13;110(3):588-595. doi: 10.4269/ajtmh.23-0487. Print 2024 Mar 6.
4
Vivax malaria: a possible stumbling block for malaria elimination in India.间日疟:印度消除疟疾的一个潜在障碍。
Front Public Health. 2024 Jan 8;11:1228217. doi: 10.3389/fpubh.2023.1228217. eCollection 2023.
5
Bridging the Gap from Molecular Surveillance to Programmatic Decisions for Malaria Control and Elimination.弥合从疟疾监测到疟疾控制与消除规划决策之间的差距。
Am J Trop Med Hyg. 2023 Dec 26;112(1_Suppl):35-47. doi: 10.4269/ajtmh.22-0749. Print 2025 Jan 7.
6
Malaria control initiatives that have the potential to be gamechangers in India's quest for malaria elimination.在印度消除疟疾的征程中,有可能成为变革者的疟疾控制举措。
Lancet Reg Health Southeast Asia. 2022 May 28;2:100009. doi: 10.1016/j.lansea.2022.04.005. eCollection 2022 Jul.
7
Tracking district-level performance in the context of achieving zero indigenous case status by 2027.在2027年实现本土病例零状态的背景下跟踪地区层面的表现。
PLOS Glob Public Health. 2023 Jan 6;3(1):e0001292. doi: 10.1371/journal.pgph.0001292. eCollection 2023.
8
Advances in Basic and Translational Research as Part of the Center for the Study of Complex Malaria in India.作为印度复杂疟疾研究中心的一部分,基础和转化研究的进展。
Am J Trop Med Hyg. 2022 Oct 11;107(4_Suppl):97-106. doi: 10.4269/ajtmh.21-1333.
9
Microscopic and submicroscopic infection by : Immunoglobulin M and A profiles as markers of intensity and exposure.微观和亚微观感染:免疫球蛋白 M 和 A 谱作为强度和暴露的标志物。
Front Cell Infect Microbiol. 2022 Sep 2;12:934321. doi: 10.3389/fcimb.2022.934321. eCollection 2022.
10
What India can learn from globally successful malaria elimination programmes.印度可以从全球成功消除疟疾规划中学到什么。
BMJ Glob Health. 2022 Jun;7(6). doi: 10.1136/bmjgh-2022-008431.

本文引用的文献

1
The Indian burden of malaria in pregnancy needs assessment.印度妊娠疟疾负担评估。
Med. 2021 May 14;2(5):464-469. doi: 10.1016/j.medj.2021.04.017.
2
Should India be considering deployment of the first malaria vaccine RTS,S/AS01?印度是否应该考虑部署首款疟疾疫苗RTS,S/AS01?
BMJ Glob Health. 2022 Jan;7(1). doi: 10.1136/bmjgh-2021-007870.
3
Validation of a Mobile Health Technology Platform (FeverTracker) for Malaria Surveillance in India: Development and Usability Study.用于印度疟疾监测的移动健康技术平台(FeverTracker)的验证:开发与可用性研究。
JMIR Form Res. 2021 Nov 10;5(11):e28951. doi: 10.2196/28951.
4
Global patterns of submicroscopic malaria infection: insights from a systematic review and meta-analysis of population surveys.全球亚微观疟疾感染模式:基于系统评价和人群调查荟萃分析的见解。
Lancet Microbe. 2021 Aug;2(8):e366-e374. doi: 10.1016/S2666-5247(21)00055-0.
5
Free Market Availability of Rapid Diagnostics Will Empower Communities To Control Malaria in India.快速诊断试剂的自由市场供应将使印度社区有能力控制疟疾。
Am J Trop Med Hyg. 2021 Jun 28;105(2):281-283. doi: 10.4269/ajtmh.21-0213.
6
Forest malaria: the prevailing obstacle for malaria control and elimination in India.森林疟疾:印度疟疾控制和消除的主要障碍。
BMJ Glob Health. 2021 May;6(5). doi: 10.1136/bmjgh-2021-005391.
7
Higher gametocyte production and mosquito infectivity in chronic compared to incident Plasmodium falciparum infections.慢性疟原虫感染比急性疟原虫感染产生更高的配子体产量和蚊子感染力。
Nat Commun. 2021 Apr 26;12(1):2443. doi: 10.1038/s41467-021-22573-7.
8
Performance and Application of Commercially Available Loop-Mediated Isothermal Amplification (LAMP) Kits in Malaria Endemic and Non-Endemic Settings.市售环介导等温扩增(LAMP)试剂盒在疟疾流行和非流行地区的性能及应用
Diagnostics (Basel). 2021 Feb 18;11(2):336. doi: 10.3390/diagnostics11020336.
9
Comparison of polymerase chain reaction, microscopy, and rapid diagnostic test in malaria detection in a high burden state (Odisha) of India.聚合酶链反应、显微镜检查和快速诊断检测在印度疟疾高发州(奥里萨邦)的疟疾检测中的比较。
Pathog Glob Health. 2021 Jun;115(4):267-272. doi: 10.1080/20477724.2021.1893484. Epub 2021 Feb 26.
10
Genotyping cognate Plasmodium falciparum in humans and mosquitoes to estimate onward transmission of asymptomatic infections.对人类和蚊子中的同源疟原虫进行基因分型,以估计无症状感染的传播。
Nat Commun. 2021 Feb 10;12(1):909. doi: 10.1038/s41467-021-21269-2.

基于聚合酶链反应的疟疾诊断在印度当前疟疾消除阶段可得到越来越多的采用。

Polymerase Chain Reaction-Based Malaria Diagnosis Can Be Increasingly Adopted during Current Phase of Malaria Elimination in India.

作者信息

Rahi Manju, Sharma Rishu, Saroha Poonam, Chaturvedi Rini, Bharti Praveen K, Sharma Amit

机构信息

Indian Council of Medical Research, New Delhi, India.

AcSIR, New Delhi, India.

出版信息

Am J Trop Med Hyg. 2022 Feb 7;106(4):1005-1012. doi: 10.4269/ajtmh.21-0966. Print 2022 Apr 6.

DOI:10.4269/ajtmh.21-0966
PMID:35130488
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8991334/
Abstract

Despite commendable progress in control of malaria in India and other countries, there are hidden reservoirs of parasites in human hosts that continually feed malaria transmission. Submicroscopic infections are a significant proportion in low-endemic settings like India, and these infections possess transmission potential. Hence, these reservoirs of infection add to the existing roadblocks for malaria elimination. It is crucial that this submerged burden of malaria is detected and treated to curtail further transmission. The currently used diagnostic tools, including the so-called "gold standard" microscopy, are incapable of detecting these submicroscopic infections and thus are suboptimal. It is an opportune time to usher in more sensitive molecular tools like polymerase chain reaction (PCR) for routine diagnosis at all levels of healthcare as an additional diagnostic tool in routine settings. PCR assays have been developed into user-friendly formats for field diagnostics and are near-point-of-collection. Because of the COVID-19 pandemic in India, these are being used rampantly across the country. The facilities created for COVID-19 diagnosis can easily be co-opted and harnessed for malaria diagnosis to augment surveillance by the inclusion of molecular techniques like PCR in the routine national malaria control program.

摘要

尽管印度和其他国家在疟疾控制方面取得了值得称赞的进展,但人类宿主中存在寄生虫的隐藏储存库,持续助长疟疾传播。在印度等低流行地区,亚显微感染占很大比例,且这些感染具有传播潜力。因此,这些感染储存库增加了消除疟疾的现有障碍。至关重要的是,要检测并治疗这种隐匿的疟疾负担,以减少进一步传播。目前使用的诊断工具,包括所谓的“金标准”显微镜检查,无法检测到这些亚显微感染,因此并不理想。现在是引入更灵敏的分子工具,如聚合酶链反应(PCR),作为各级医疗保健常规诊断的额外诊断工具的适当时机。PCR检测已发展成便于现场诊断的用户友好形式,且接近采集点。由于印度的新冠疫情,这些检测在全国被大量使用。为新冠诊断建立的设施可轻松用于疟疾诊断,通过将PCR等分子技术纳入国家常规疟疾控制项目来加强监测。